Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EOLS – Evolus, Inc.

Evolus, Inc. Common Stock
EOLS
$10.11
Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $651,848,320.00
EPSttm : -0.89
finviz dynamic chart for EOLS
Evolus, Inc. Common Stock
$10.11
0.20%
$0.02

Float Short %

15.36

Margin Of Safety %

Put/Call OI Ratio

0.04

EPS Next Q Diff

EPS Last/This Y

0.75

EPS This/Next Y

0.76

Price

10.13

Target Price

23.57

Analyst Recom

1

Performance Q

-26.43

Relative Volume

1.63

Beta

1.05

Ticker: EOLS




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-14EOLS10.290.130.106424
2025-04-15EOLS10.240.134.386517
2025-04-16EOLS10.110.141.676584
2025-04-17EOLS10.790.130.046533
2025-04-18EOLS10.790.130.046533
2025-04-21EOLS10.390.050.003996
2025-04-22EOLS10.450.050.073996
2025-04-23EOLS11.230.050.004149
2025-04-24EOLS11.540.040.194638
2025-04-25EOLS11.650.0422471910112360.219512195121954638
2025-04-28EOLS11.310.04556514045565104727
2025-04-29EOLS11.580.020.079077
2025-04-30EOLS11.320.020.009079
2025-05-01EOLS11.790.010.4714079
2025-05-02EOLS12.060.020.0714119
2025-05-05EOLS12.010.020.0014191
2025-05-06EOLS11.640.0210.9114040
2025-05-07EOLS11.760.050.0214433
2025-05-08EOLS10.090.040.0316958
2025-05-09EOLS9.780.040.0617935
2025-05-12EOLS9.990.040.0017966
2025-05-13EOLS10.150.040.0018043
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-14EOLS10.27-9.48.5-0.06
2025-04-15EOLS10.23-9.410.0-0.06
2025-04-16EOLS10.12-9.410.2-0.06
2025-04-17EOLS10.79-9.48.6-0.06
2025-04-18EOLS10.79-9.49.9-0.11
2025-04-21EOLS10.38-30.610.7-0.11
2025-04-22EOLS10.46-30.69.8-0.11
2025-04-23EOLS11.23-30.68.5-0.11
2025-04-24EOLS11.54-30.69.4-0.11
2025-04-25EOLS11.65-30.69.8-0.12
2025-04-28EOLS11.31-30.610.5-0.12
2025-04-29EOLS11.57-30.69.5-0.12
2025-04-30EOLS11.39-30.610.3-0.12
2025-05-01EOLS11.79-30.69.2-0.12
2025-05-02EOLS12.08-30.69.5-0.12
2025-05-05EOLS12.01-30.610.1-0.12
2025-05-06EOLS11.61-30.610.6-0.12
2025-05-07EOLS11.76-30.69.7-0.12
2025-05-08EOLS10.09-30.612.8-0.12
2025-05-09EOLS9.78-30.610.6-0.06
2025-05-12EOLS9.98-30.69.6-0.06
2025-05-13EOLS10.13-18.95.7-0.06
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-14EOLS-2.333.6112.75
2025-04-15EOLS-2.333.6112.75
2025-04-16EOLS-2.333.6112.75
2025-04-17EOLS-2.333.6112.75
2025-04-18EOLS-2.333.6112.75
2025-04-21EOLS-2.335.4012.75
2025-04-22EOLS-2.335.4012.75
2025-04-23EOLS-2.335.4012.75
2025-04-24EOLS-2.335.4012.75
2025-04-25EOLS-2.335.4012.75
2025-04-28EOLS-2.335.4913.67
2025-04-29EOLS-2.335.4913.67
2025-04-30EOLS-2.335.4913.67
2025-05-01EOLS-2.305.4913.67
2025-05-02EOLS-2.305.4913.49
2025-05-05EOLS-2.305.2713.49
2025-05-06EOLS-2.305.2713.49
2025-05-07EOLS-2.305.2713.49
2025-05-08EOLS-2.305.2713.49
2025-05-09EOLS-2.305.2713.49
2025-05-12EOLS-2.304.9415.36
2025-05-13EOLS-2.304.9415.36
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.06

Insider Transactions

-2.3

Institutional Transactions

4.94

Beta

1.05

Average Sales Estimate Current Quarter

82

Average Sales Estimate Next Quarter

85

Fair Value

Quality Score

40

Growth Score

55

Sentiment Score

4

Actual DrawDown %

43.2

Max Drawdown 5-Year %

-68.4

Target Price

23.57

P/E

Forward P/E

17.51

PEG

P/S

2.37

P/B

P/Free Cash Flow

EPS

-0.89

Average EPS Est. Cur. Y​

-0.06

EPS Next Y. (Est.)

0.7

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-20.4

Relative Volume

1.63

Return on Equity vs Sector %

-936.8

Return on Equity vs Industry %

-920.7

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

EBIT Estimation

5.7
Evolus, Inc. Common Stock
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 372
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading